Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-10-23-Speech-2-374-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-10-23"^^xsd:date2
dcterms:Is Part Of	lp_eu:Protocol to the Euro-Mediterranean Agreement establishing an association between the EC and Israel on Conformity Assessment and Acceptance of Industrial Products (CAA) (A7-0289/2012 - Vital Moreira) (vote)2
dcterms:Language	"fr"^^xsd:language2
lpv:document identification number	"en.20121023.41.2-374-000"2
lpv:hasSubsequent	lp_eu:2012-10-23-Speech-2-375-0002
lpv:speaker	lp:Véronique De Keyser2
lpv:spokenAs	member; DROI (2012-01-19--2014-06-30)3 member; Delegation to the ACP-EU Joint Parliamentary Assembly (2009-09-16--2014-06-30)3 vice-chair; S&D (2012-06-07--2014-06-30)3 substitute; Delegation for relations with the Palestinian Legislative Council (2009-09-16--2014-06-30)3 member; DEVE (2012-01-19--2014-06-30)3 substitute; AFET (2012-01-19--2014-06-30)3 unknown; Parti Socialiste (2009-07-14--2014-06-30)3
lpv:translated text	". Madam President, as I stated in the debate an hour ago, my group is asking for this report to be referred back to committee for legal reasons. If we say ‘yes’ to this agreement on the pharmaceutical sector, we will no longer have any right of scrutiny, as Parliament, over other sectors, such as cosmetics, which could be included in the future. As a result, our role as co-legislator is ambiguous and we are therefore frustrated."@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph